Desirudin how supplied storage and handling: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Desirudin}} {{CMG}}; {{AE}} {{SS}} ==How Supplied Storage and Handling== Iprivask (desirudin for injection) is supplied as a single dose (15.75 mg) lyophilized po...")
 
(Redirected page to Desirudin#How Supplied)
 
Line 1: Line 1:
__NOTOC__
#REDIRECT [[Desirudin#How Supplied]]
{{Desirudin}}
{{CMG}}; {{AE}} {{SS}}
 
==How Supplied Storage and Handling==
Iprivask (desirudin for injection) is supplied as a single dose (15.75 mg) lyophilized powder with an accompanying sterile, non-pyrogenic diluent [0.6 mL of Mannitol USP (3%) in Water for Injection].
 
Each Iprivask Vial contains 15.75 mg desirudin and the following inactive ingredients: 1.31 mg anhydrous magnesium chloride USP, sodium hydroxide for injection USP.
 
Each carton of Iprivask (desirudin for injection) contains 10 individual doses of Iprivask, each in a separate tray.
 
Each tray of Iprivask (desirudin for injection) contains:
 
*One (1) x 15.75 mg Single Dose Vial
*One (1) x 0.6 mL Prefilled syringe of Diluent
*One (1) Eclipse™ needle
*One (1) Vial Adapter
 
Each prefilled syringe of diluent contains 0.6 mL Mannitol USP (3% w/v) in Water for Injection provided for reconstitution of the desirudin lyophilized powder.
 
Storage:
 
Protect from light.
 
Unopened vials or prefilled syringes: Store at 25°C (77°F); excursions permitted to 15–30°C (59-86°F). [See USP Controlled Room Temperature.]
 
Once Iprivask is reconstituted it may be used for up to 24 hours, when stored as indicated above. After 24 hours discard the solution.
 
Keep this and all medicines out of the reach of children.
 
<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = IPRIVASK (DESIRUDIN) KIT [MARATHON PHARMACEUTICALS, LLC] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d768eca6-b25d-4aec-905f-b6a89e89ff29 | publisher =  | date =  | accessdate = 3 February 2014 }}</ref>
 
 
==References==
 
{{Reflist|2}}
 
[[Category:Direct thrombin (II) inhibitors]]
[[Category:Anticoagulants]]
[[Category:Cardiovascular Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}

Latest revision as of 22:29, 21 July 2014